Sciences Ltd. Roivant
Director at Immunovant, Inc. (IMVT)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-5.4%
vs. S&P 500-3.4%
Beat the market0%
Paper profit on buys+$158M
Total bought / sold$350M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 12SEC | IMVTImmunovant, Inc. | Buy | 16,666,666113,317,007 held (+17%) | $21.00 | $350M | +45.1% |
- Buy
Director Sciences Ltd. Roivant bought $350M of IMVT at $21.00 — first open-market purchase in our records.